Bücher der Reihe Springer Series on Epidemiology and Public Health

Complementing these findings, part two reviews the evidence base regarding the variables, separately and in combination, having the most significant impact on young people's development of obesity, including:* Genetic and nutrigenomic factors.

This book examines the new knowledge that has been gained from the objective monitoring of habitual physical activity by means of pedometers and accelerometers.

"Methods of Clinical Epidemiology" serves as a text on methods useful to clinical researchers. This book will be of use to postgraduate students in clinical epidemiology as well as clinical researchers at the start of their careers.

Complementing these findings, part two reviews the evidence base regarding the variables, separately and in combination, having the most significant impact on young people's development of obesity, including:* Genetic and nutrigenomic factors.

In young children, questionnaires have to be completed by proxies, usually their parents, while older children, particularly adolescents, can provide a major part of the requested information themselves.This book presents suitable designs, methods and instruments for data collection in studies of children and adolescents.

Building on the contributions of leading experts in the field, this book presents current knowledge about sedentary behaviour, its medical and public health significance, its correlates and determinants, measurement techniques, and recommendations for addressing this behaviour at the individual, community, environmental, and policy level.

This book examines the new knowledge that has been gained from the objective monitoring of habitual physical activity by means of pedometers and accelerometers.

In young children, questionnaires have to be completed by proxies, usually their parents, while older children, particularly adolescents, can provide a major part of the requested information themselves.This book presents suitable designs, methods and instruments for data collection in studies of children and adolescents.

This book is open access under a CC BY-NC-ND 4.0 license. This open access book is the first compilation that reviews a wide range of social determinants of health (SDHs) for non-communicable diseases (NCDs) and healthy ageing in Japan.

This book is open access under a CC BY-NC-ND 4.0 license. This open access book is the first compilation that reviews a wide range of social determinants of health (SDHs) for non-communicable diseases (NCDs) and healthy ageing in Japan.

This book allows readers to gain an in-depth understanding of the role of real-world data in pharmacoepidemiology, and highlights the strengths and limitations of the respective databases with regard to pharmacoepidemiological research.Over the past decade, the increasing use of real-world data in pharmacoepidemiological research has been accompanied by a growing recognition of the value of real-world evidence in clinical and regulatory decision-making. Electronic healthcare databases allow analyses of drug and vaccine utilization in routine care after approval, as well as investigations of their comparative effectiveness and safety. They are especially useful for the identification of rare risks and rare drug exposures over long periods of time, and as such sustainably extend the basis for drug safety research. This book provides an introduction to the role of real-world data in pharmacoepidemiological research and the main developments in the last 15 years. It also offers a comprehensive overview of the general classification characteristics of databases, together with their strengths and limitations, and a detailed description of 21 individual databases, written by professionals who work with or maintain them.

This book allows readers to gain an in-depth understanding of the role of real-world data in pharmacoepidemiology, and highlights the strengths and limitations of the respective databases with regard to pharmacoepidemiological research.Over the past decade, the increasing use of real-world data in pharmacoepidemiological research has been accompanied by a growing recognition of the value of real-world evidence in clinical and regulatory decision-making. Electronic healthcare databases allow analyses of drug and vaccine utilization in routine care after approval, as well as investigations of their comparative effectiveness and safety. They are especially useful for the identification of rare risks and rare drug exposures over long periods of time, and as such sustainably extend the basis for drug safety research. This book provides an introduction to the role of real-world data in pharmacoepidemiological research and the main developments in the last 15years. It also offers a comprehensive overview of the general classification characteristics of databases, together with their strengths and limitations, and a detailed description of 21 individual databases, written by professionals who work with or maintain them.